PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy
eLife · 2024
DOI: 10.7554/elife.91260 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Teruhiko Yoshida und 16 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, United States. Hauptthemen laut MEDLINE: AIDS-Associated Nephropathy, eIF-2 Kinase, Mice, Transgenic, Mitochondria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
HIV disease remains prevalent in the USA and chronic kidney disease remains a major cause of morbidity in HIV-1-positive patients. Host double-stranded RNA (dsRNA)-activated protein kinase (PKR) is a sensor for viral dsRNA, including HIV-1. We show that PKR inhibition by compound C16 ameliorates the HIV-associated nephropathy (HIVAN) kidney phenotype in the Tg26 transgenic mouse model, with reversal of mitochondrial dysfunction. Combined analysis of single-nucleus RNA-seq and bulk RNA-seq data revealed that oxidative phosphorylation was one of the most downregulated pathways and identified signal transducer and activator of transcription (STAT3) as a potential mediating factor. We identified in Tg26 mice a novel proximal tubular cell cluster enriched in mitochondrial transcripts. Podocytes showed high levels of HIV-1 gene expression and dysregulation of cytoskeleton-related genes, and these cells dedifferentiated. In injured proximal tubules, cell-cell interaction analysis indicated activation of the pro-fibrogenic PKR-STAT3-platelet-derived growth factor (PDGF)-D pathway. These findings suggest that PKR inhibition and mitochondrial rescue are potential novel therapeutic approaches for HIVAN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, United States.
- Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, United States.
- Department of Pathology and Anatomical Sciences, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, United States.
- Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, United States.
- Polycystic Kidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, United States.
- Frederick National Laboratory for Cancer Research, NCI, NIH, Frederick, United States.
ORCID-Profile: Teruhiko Yoshida, Komuraiah Myakala, Xiaoping Yang, Moshe Levi
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Intramural NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Cancer Institute
Zitieren
APA
Yoshida, T., Latt, K. Z., Rosenberg, A. Z., Santo, B. A., Myakala, K., Ishimoto, Y., Zhao, Y., Shrivastav, S., Jones, B. A., Yang, X., Wang, X. X., Tutino, V. M., Sarder, P., Levi, M., Okamoto, K., Winkler, C. A., & Kopp, J. B. (2024). PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy. eLife. https://doi.org/10.7554/elife.91260
Vancouver
Yoshida T, Latt KZ, Rosenberg AZ, Santo BA, Myakala K, Ishimoto Y, et al. PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy. eLife. 2024. doi:10.7554/elife.91260
BibTeX
@article{Yoshida2024,
author = {Yoshida, Teruhiko and Latt, Khun Zaw and Rosenberg, Avi Z and Santo, Briana A and Myakala, Komuraiah and Ishimoto, Yu and Zhao, Yongmei and Shrivastav, Shashi and Jones, Bryce A and Yang, Xiaoping and Wang, Xiaoxin X and Tutino, Vincent M and Sarder, Pinaki and Levi, Moshe and Okamoto, Koji and Winkler, Cheryl A and Kopp, Jeffrey B},
title = {PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.91260}
}
EUVIMED